{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-238120","form_type":"8-K","ticker":"CRNX","cik":"0001658247","company_name":"Crinetics Pharmaceuticals, Inc.","filed_at":"2024-10-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.130775+00:00","generated_at":"2026-05-30T13:45:19.993329+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Crinetics COO James Hassard departs; consulting deal through Jan 2025 at $200/hr","bullets":["James Hassard ceased as COO effective Oct 14, 2024; consulting and separation agreements signed Oct 10.","Consulting agreement: up to 20 hrs/month at $200/hr through Jan 15, 2025 for commercial launch prep.","Separation agreement provides payments/benefits for termination without cause per employment contract.","Outstanding equity awards continue to vest through Jan 15, 2025; prior employment agreement terminated."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-238120","json":"https://secwatch.observer/filing/0001193125-24-238120.json","markdown":"https://secwatch.observer/filing/0001193125-24-238120.md","text":"https://secwatch.observer/filing/0001193125-24-238120.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1658247/000119312524238120/0001193125-24-238120-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1658247/000119312524238120/d850938d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T13:45:19.993329+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fd48603086","claim":"James Hassard departed as Chief Operating Officer at Crinetics Pharmaceuticals, Inc..","evidence_excerpt":"James Hassard ceased serving as the Chief Operating Officer of the Company, effective October 14, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1658247/000119312524238120/0001193125-24-238120-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}